SPDR S&P Biotech ETF
674 hedge funds and large institutions have $6.63B invested in SPDR S&P Biotech ETF in 2023 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 182 increasing their positions, 245 reducing their positions, and 91 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
26% less repeat investments, than reductions
Existing positions increased: 182 | Existing positions reduced: 245
27% less call options, than puts
Call options by funds: $1.32B | Put options by funds: $1.8B
31% less first-time investments, than exits
New positions opened: 63 | Existing positions closed: 91
Holders
674
Holding in Top 10
17
Calls
$1.32B
Puts
$1.8B
Top Buyers
| 1 | +$184M | |
| 2 | +$103M | |
| 3 | +$91.4M | |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$65.7M |
| 5 |
Squarepoint
New York
|
+$61.3M |
Top Sellers
| 1 | -$186M | |
| 2 | -$67.5M | |
| 3 | -$36.6M | |
| 4 |
HF
HRT Financial
New York
|
-$27.6M |
| 5 |
Millennium Management
New York
|
-$19.9M |